Ross Thomas M.'s Form 4 filing
Maxcyte, Inc. (MXCT) · filed Jun 24, 2024
- Accession no.
- 0001415889-24-017956
- Filed
- Jun 24, 2024
- Trade date
- Jun 20, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $136.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ross Thomas M.CIK 0001874572 | Officer (EVP, GLOBAL SALES) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 20, 2024 | Common Stock | MOption exerciseAcquired | +33,333 | $1.64 | +$54,666.12 | 58,333 | Direct | |
| Jun 20, 2024 | Common Stock | SSaleDisposed | −33,333 | $4.09 | −$136,331.97 | 25,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 20, 2024 | Common Stock | MOption exerciseDisposed | −33,333 | $0.00 | $0 | 66,667 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.